STONY BROOK, N.Y.--(BUSINESS WIRE)--Coferon, Inc. announced today that it is one of fifteen early stage companies selected by BioCentury to present in their “New Wave” track at the BioCentury “Future Leaders in Biotech Conference” to be held on Friday, 20th March, 2015 in New York.
The Company’s presentation will focus on programs actively available for partnering with major pharmaceutical and biotechnology companies including the Company’s proprietary MYC program, which represents the first demonstration of the ability to use self-assembling coferon dimers to inhibit challenging Protein-Protein Interaction (PPI) targets inside the cell.
Help employers find you! Check out all the jobs and post your resume.
The Company’s presentation will focus on programs actively available for partnering with major pharmaceutical and biotechnology companies including the Company’s proprietary MYC program, which represents the first demonstration of the ability to use self-assembling coferon dimers to inhibit challenging Protein-Protein Interaction (PPI) targets inside the cell.
Help employers find you! Check out all the jobs and post your resume.
